ARCHIVES

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

July 28, 2006

Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI.

October 6, 2000

House committee asks GAO to investigate Klausner-era NCI contract with Harvard University.

September 9, 2005

Consensus Conference On Receptors Planned

June 22, 1979

Pragmatists vs. Purists: Colon Cancer Screening Guideline Triggers Debate.

October 10, 2008

BRCA Status Can Guide Ovarian Cancer Treatment

April 25, 2008